Proteinuria Self-Test For Early Detection of Pre-Eclampsia

This condition is a leading cause of maternal mortality in developing countries, particularly in rural areas where access to healthcare is limited. The proteinuria self-test pen was developed by Jhpiego, in collaboration with JHU-CBID engineers, the USAID/Nepal Mission, and MCHIP. The test is designed to be simple, low-cost, and non-invasive, allowing pregnant women to use it at home. The test paper is prepared by a community health agent or volunteer, who then distributes it to the pregnant woman. The woman uses the self-test at home, and the results are interpreted by the community health agent or volunteer. The proteinuria self-test pen underwent laboratory-based validation and field testing in Nepal. The initial prototype was modified based on the results of the laboratory-based validation study and the ANC clinic study. The reagent and delivery system were improved to make the test more practical and suitable for low-resource settings. A small-scale pilot study was conducted in a rural district in southern Nepal to assess the acceptability and feasibility of utilizing the proteinuria self-test at the community level. The study was conducted in November 2011 and was stopped early due to unexpected results. However, the study provided valuable information on the interpretation of the test results, storage, and training of community health volunteers. The key lessons learned from the prototype development and field tests include the importance of proper interpretation of test results, storage, and training of community health volunteers. The study also highlighted the need for further improvements to the reagent and delivery system. The proteinuria self-test pen has the potential to be a valuable tool in reducing maternal mortality related to pre-eclampsia/eclampsia in developing countries. Further research and development are needed to refine the test and make it more widely available. The proteinuria self-test pen is designed to be used in low-resource settings, where access to healthcare is limited. The test is simple, low-cost, and non-invasive, making it an ideal tool for community-based healthcare programs. The test can be used by community health agents or volunteers, who can distribute the test paper to pregnant women and interpret the results. The proteinuria self-test pen has undergone rigorous testing and evaluation, including laboratory-based validation and field testing in Nepal. The results of these studies have informed the development of the test and have highlighted the need for further improvements.